NICE’s interim second draft guidance does not recommend lecanemab for use within the NHS in England and Wales at this time.
Octapharma has announced that, for the first time in almost 30 years, NHS patients are receiving medicines made from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback